The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends, and Updates (10/9/18)
- New: HIV Testing Pocket Guide (10/8/18)
- PrEP for Transgender Women Meeting Materials and Report Now Available (10/5/18)
- Updated HIV Testing Guideline (10/3/18)
- Updates to the Diagnosis and Management of Acute HIV Guideline (8-24-18)
- Updates to the HAV-HIV Coinfection Guideline (8-24-18)
- New: Pocket Guide to HPV in Patients with HIV (8/1/18)
- New: Pocket Guide to Management of Periodontal Disease in HIV (8/1/18)
- AETC NCRC Updates (10/11/18)
- New & Updated HIV Drug Fact Sheets on AIDSinfo (10/4/18)
- HHS Guidance on Caring for Persons with HIV in Disaster Areas Updated (9/18/18)
- FDA: Dolutegrevir Label Updates Regarding Neural Tube Defects (9/6/18)
- AIDSinfo Releases Fact Sheets on Two New HIV Medications, Pifeltro & Delstrigo (9/6/18)
Is High-Sensitivity CRP a Useful Cardiovascular Risk Predictor for Women with HIV? Risk of cardiovascular disease (CVD) and ischemic stroke in women with HIV appears to be greater than in men with HIV and in women who do not have HIV. Read more
Chronic Comorbidities among People Living with HIV Infection: As a result of potent and tolerable antiretroviral therapy (ART), people with HIV infection (PLWH) are living longer. However, rates of chronic, non-communicable end-organ diseases are higher in PLWH than in people of similar ages who do not have HIV infection. Read more
- NYS Medicaid Update (10/12/18)
- Dear Colleague Letter: Information Related to Prevention of MTCT: Intrapartum ART/ Prophylaxis; Neonatal ART Prophylaxis; HIV Testing of Infants and Children <24 months (10/3/18)
- CEI Newsletter (9/18/18)
- Dear Colleague Letter: Developments in the State's HIV Prevention & Partner Service Programming (9/7/18)
- Three New STD Clinical Cards (8/14/18)
- 10/20-10/24/18: National Conference on Correctional Healthcare (Las Vegas, NV)
- 10/21/18: HIVR4P 2018: AIDS Vaccine, Microbicide & ARV-based Prevention Science (Madrid, ES)
- 10/24/18: CEI: HCV Intensive Training Preceptorship Program (New York, NY)
- 10/26/18: Interprofessional Care for the 21st Century (Philadelphia, PA)
- 10/28/18: HIV Drug Therapy Glasgow (Glasgow, UK)
- 10/16/18: Mountain West AETC: Controversial Issues in the Management of Antiretroviral Therapy
- 10/17/18: Northeast/Caribbean AETC: Sexual Health History Taking
- 10/17/18: CEI This Month in HIV: Basics of HIV Resistance Testing
- 10/18/18: CAPTC: Age is Not Just Number: HIV Prevention with People Ages 50 & Older
- 10/24/18: CEI STD ECHO: Undetectable = Untransmittable